Trastuzumab Active Not Recruiting Phase 1 Trials for Breast Cancer Treatment

Active Not RecruitingTreatment1 IdentifierTitleDrugs
NCT02167854Open-Label Study Evaluating the Safety and Tolerability of LJM716, BYL719 and Trastuzumab in Patients With Metastatic HER2+ Breast Cancer
NCT00393783Xenogeneic HER2/Neu DNA Immunization for Patients With Metastatic and High Risk Breast Cancer: A Phase I Study to Assess Safety and Immunogenicity
NCT01304797Safety and Pharmacokinetic Study of MM-302 in Patients With Advanced Breast Cancer